from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3899c/-

LFCtreatmentdescriptionclass of inhibitor

1.380

Amikacinug/mL Amikacintranslation

0.836

Cap5-10ug/mL Capreomycintranslation

2.043

Rox10-50 ug/mL Roxithromycintranslation

0.815

SM2-5 ug/mL Streptomycintranslation

2.033

Tet5-10 ug/mL Tetracyclinetranslation

-0.558

Rif0.2-5ug/mL Rifampicintranscription

0.241

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.989

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.065

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.265

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.451

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.071

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.075

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.949

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.573

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.451

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.187

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.099

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.151

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.505

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.878

KCN5-20 ug/mL Potassium cyaniderespiration

-0.179

NaN30.2-2 mM Sodium aziderespiration

0.130

Nigericin50 uM Nigericinrespiration

-0.267

TRC10-150 ug/mL Triclosanrespiration

0.688

TRZ10-25 ug/mL Thioridazinerespiration

1.658

Valinomycin0.5-10 uM Valinomycinrespiration

0.100

ZnSO42 mM ZnSO4respiration

-0.812

menadione6-10 ug/mL Menadionerespiration

-0.129

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.408

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.425

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.041

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.827

NRP_1Non-replicating persistence stage 1dosRassociated

0.578

Amp0.2mg/mL AmpicillincellWall

0.548

Cephalexin20-100 ug/mL CephalexincellWall

-0.142

Cerulenin0.32-5 ug/mL CerulenincellWall

0.684

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.056

EMB10-20 ug/mL EthambutolcellWall

-0.103

Eta12-40 ug/mL EthionamidecellWall

0.555

INH0.2-0.4 ug/mL IsoniazidcellWall

0.153

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.414

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.746

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.373

BZA0.12 mg/mL BenzamidearomaticAmides

-0.212

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.084

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.936

H2O24 mM hydrogen peroxideDNAdamaging

-0.066

Levo10 ug/mL LevofloxacinDNAdamaging

-1.015

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.398

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.071

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.669

UVUV-irradiationDNAdamaging

-0.871

ARP41-4 ug/mL Antitubercular compound ARP4?

0.493

Antimycin12.5-50 ug/mL Antimycin A?

0.128

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.065

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.204

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.593

PA8240.2-2 ug/mL PA-824?

-0.019

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.312

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.020

Verapamil50 uM Verapamil?

1.432

mercaptoethanol2 mM 2-Mercaptoethanol?

0.117

methoxatin10-20 ug/mL Methoxatin?